Terazosin
- Product NDC
- 42291-820
- 11-digit product format
- 422910820
- Labeler code
- 42291
- Product ID
- 42291-820_3a9ec205-cdb5-e131-e063-6294a90acb60
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Terazosin Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA075317
- Marketing category
- ANDA
- Marketing start
- 2020-03-30
- Substance
- TERAZOSIN HYDROCHLORIDE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Terazosin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TERAZOSIN HYDROCHLORIDE | 1 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | D32S14F082 |
| Rxcui | 260376, 313215, 313217, 313219 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 42291-820-10 | Terazosin | 1000 in 1 BOTTLE | CAPSULE | 1000 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 42291-820 | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) CAPSULE [AVKARE] | 3 | Current NDC, Legacy NDC, 1 package rows | 20241010_a2137488-8554-e84f-e053-2995a90a796c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42291-820-10 | 42291082010 | 1000 CAPSULE in 1 BOTTLE (42291-820-10) | 1000 capsule | 2020-03-30 | 0000-00-00 | No | No | Current |